StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

China SXT Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2026 it was $1.14M, down 34.6% from the year before. The highest annual figure on record is $7.02M in fiscal 2018.

Annual revenue

PeriodPeriod endValueChange
FY2026Mar 31, 2026$1.14M-34.6%
FY2025Mar 31, 2025$1.74M-9.7%
FY2024Mar 31, 2024$1.93M-2.2%
FY2023Mar 31, 2023$1.97M-24.2%
FY2022Mar 31, 2022$2.60M-45.5%
FY2021Mar 31, 2021$4.78M-7.5%
FY2020Mar 31, 2020$5.16M-26.4%
FY2019Mar 31, 2019$7.01M-0.1%
FY2018Mar 31, 2018$7.02M+43.8%
FY2017Mar 31, 2017$4.88M–

More China SXT Pharmaceuticals figures

See a number that looks wrong?